Stock Market Update - September 28, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. KNRX - Knorex Ltd.
Price: $1.23 | Change: +304.61% ($0.926)
KNRX shares experienced a monumental 304.61% gain, surging on the news of a significant strategic move. Knorex Ltd. announced its intention to "carve out" or separate its publisher monetization subsidiary, AscendX Media Technologies, into an independently capitalized entity.
Under this plan, Knorex will retain a minority stake in the new AscendX business, allowing it to reallocate capital and resources towards its core strategic priorities. These include its flagship KNOREX XPO programmatic advertising platform and KAIROS Agentic AI initiatives, aiming to sharpen the company's focus.
The market reacted very positively to this development, particularly as AscendX is transitioning from product development to commercial deployment and is already in advanced discussions to onboard new global publishers. Investors appear bullish on Knorex's strategic refocusing and the potential of the new independent AscendX entity.
2. KOD - Kodiak Sciences Inc.
Price: $89.92 | Change: +177.96% ($57.57)
KOD saw its stock price soar by an impressive 177.96%! This significant surge followed exciting news from Kodiak Sciences regarding its late-stage clinical trials. On September 28, 2026, the biotech firm announced strong positive results for its experimental drugs, Zenkuda and KSI-501, which are being developed to treat wet age-related macular degeneration (wet AMD), a serious eye condition.
What made this news particularly impactful was Zenkuda's demonstrated durability. It not only matched an existing leading treatment in vision improvement but also allowed a significant portion of patients to maintain those gains with injections every six months – far less frequent than the standard every eight weeks for current therapies. This potential for a less burdensome treatment, coupled with positive safety data, means Kodiak Sciences is now on track to submit Zenkuda for regulatory approval, potentially offering a new standard of care for various retinal diseases.
3. SOAR - Volato Group, Inc.
Price: $0.3188 | Change: +77.60% ($0.1393)
SOAR absolutely surged with a 77.60% gain, making headlines for its impressive upward movement. This significant spike was driven by a major announcement from Volato Group, Inc. regarding its new subsidiary, Alignment Engine.
The company revealed on September 28, 2026, that Alignment Engine secured a massive artificial intelligence (AI) infrastructure contract. This deal, valued at approximately $1.17 billion over four years, involves providing dedicated AMD GPU infrastructure to a major, undisclosed AI customer. The agreement also includes substantial contractual prepayments of around $133 million.
What makes this particularly interesting is that it's Alignment Engine's first major customer commitment since its recent merger with Volato Group. This landmark deal effectively positions Volato Group as a significant player in the rapidly expanding AI infrastructure sector.
4. LFCR - Lifecore Biomedical, Inc.
Price: $6.52 | Change: +55.24% ($2.32)
LFCR just made a huge splash, surging an impressive 55.24% following the announcement that Lifecore Biomedical, Inc. is being acquired by Webster Equity Partners. This significant deal, revealed on September 28, 2026, values the company at up to $663.7 million, including future performance-based payments.
Lifecore shareholders are slated to receive $6.28 in cash per share at closing, which represents a substantial premium of nearly 50% over its price before the news broke. Adding an intriguing twist, shareholders will also get a "Contingent Value Right" (CVR) per share. This CVR offers the potential for additional cash payments if Lifecore achieves specific revenue and earnings milestones through 2030. If all these goals are met, the total potential payout could reach $9.67 per share. Once the acquisition closes, expected by the end of 2026, Lifecore's stock will be delisted from Nasdaq.
5. EGG - Enigmatig Limited
Price: $4.25 | Change: +51.79% ($1.45)
EGG:AMEX recently saw a substantial 51.79% gain, grabbing attention around September 29, 2026. Shares of Enigmatig Limited surged dramatically, with reports indicating a rally that exceeded 47% during regular trading hours on some of those days.
What makes this movement particularly intriguing is the mystery surrounding its cause. Despite the significant increase in both price and trading volume, financial news outlets and analyst coverage at the time found no clear public catalyst, such as new partnerships or financial guidance, to explain the sudden spike.
Enigmatig Limited operates as an international consultancy firm specializing in cross-border business solutions. The stock has a history of demonstrating extreme volatility, with notable daily price swings observed earlier in 2026. This latest unexplained rally simply adds another chapter to its "enigmatic" market behavior.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.